Table 2.
Comparison of the clinical data of all patients during the decompensated and compensated states
| Clinical data | Decompensated state | Compensated state | P value |
|---|---|---|---|
| HR (b/min) | 91.7 ± 13.4 | 75.3 ± 6.9 | < 0.001 |
| pSBP (mmHg) | 114.3 ± 19.6 | 112.7 ± 12.4 | 0.158 |
| pDBP (mmHg) | 71.6 ± 11.2 | 70.6 ± 8.0 | 0.125 |
| pPP (mmHg) | 42.7 ± 14.3 | 42.0 ± 9.9 | 0.528 |
| cSBP (mmHg) | 103 ± 18.4 | 100.3 ± 12.4 | 0.011 |
| cDBP (mmHg) | 71.8 ± 11.4 | 69.9 ± 7.9 | 0.007 |
| cPP (mmHg) | 30.7 ± 12.4 | 30.4 ± 9.0 | 0.705 |
| AP (mmHg) | 12.5 ± 7.8 | 6.3 ± 4.1 | < 0.001 |
| AIx@75 (%) | 21.7 ± 10.2 | 14.1 ± 5.9 | < 0.001 |
| RM (%) | 59.0 ± 9.3 | 45.5 ± 9.2 | < 0.001 |
| PWV (m/sec) | 8.9 ± 1.3 | 8.0 ± 1.3 | < 0.001 |
| LVEDD (cm) | 6.8 ± 0.4 | 6.7 ± 0.4 | 0.367 |
| LVESD (cm) | 5.2 ± 0.5 | 5.2 ± 0.6 | 0.052 |
| EF (%) | 27.6 ± 3.5 | 28.0 ± 3.7 | 0.005 |
| LA diameter (cm) | 5.0 ± 0.4 | 4.9 ± 0.4 | 0.01 |
| Mitral annular E/e' | 18.9 ± 4.1 | 15.7 ± 3.0 | < 0.001 |
| EPASP (mmHg) | 46.3 ± 9.1 | 44.8 ± 7.9 | 0.001 |
| Hb (g/dl) | 12.2 ± 2.2 | 12.4 ± 1.9 | 0.007 |
| Creatinine (mg/dl) | 0.9 ± 0.2 | 0.8 ± 0.1 | < 0.001 |
| Na (mEq/L) | 129.4 ± 5.5 | 130.8 ± 5.1 | 0.002 |
| K (mEq/L) | 4.3 ± 0.8 | 4.2 ± 0.6 | 0.581 |
Significant P value (<0.05) is presented in bold
Data are presented as mean ± SD
AIx@75, augmentation index corrected to heart rate of 75 beats per minute; AP, augmentation pressure; cDBP, central diastolic blood pressure; cPP, central pulse pressure; cSBP, central systolic blood pressure; EF, ejection fraction; EPASP, estimated pulmonary artery systolic pressure; Hb, haemoglobin; HR, heart rate; LA, left atrium; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; LVH, left ventricular hypertrophy; pDBP, peripheral diastolic blood pressure; pPP, peripheral pulse pressure; pSBP, peripheral systolic blood pressure; PWV, pulse wave velocity; RM, reflection magnitude; RV, right ventricle; RWMAs, regional wall motion abnormalities